BioLife Solutions, Inc. (BLFS)
BLFS · Electromedical & Electrotherapeutic Apparatus · Bothell, WA · filing with the SEC since 1995
Grade5.1
◀ Past 3.3● Present 6.3▶ Future 5.4
Filings
282 filings since 2017 beside 1,028 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026Due nextLarge accelerated filer
10-K
Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends.
by Mar 1, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 37 days after the quarter ended. The proxy statement was last filed Jul 8, 2025.
Filings a yearinsider forms included
103124178192220107152115
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Oct 6, 2026.Officer or director change (8-K item 5.02): 4 times in the last 36 months, the newest Oct 6, 2026.SEC letters: 4 in the last 36 months, the newest Nov 30, 2023.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Oct 6, 2026
8-K items 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 5.07, 9.01
Purchase or sale of a business completed; Listing warning from its exchange; Change to shareholders' rights; Change of control; Officer or director change; Charter, bylaw or fiscal-year change; Shareholder vote · Current report
Jul 22, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Jul 21, 2026
40 of 282 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.